Bluesky Facebook Reddit Email

Daily insulin dose, cancer risk among patients with type 1 diabetes

07.28.22 | JAMA Network

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

About The Study: This study investigated the associations of risk factors with cancer incidence in patients with type 1 diabetes on a daily regimen of insulin.

Authors: Yuanjie Mao, M.D., Ph.D., of Ohio University in Athens, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2022.2960)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2960?guestAccessKey=b87b1296-2d13-4778-adc8-6ef8cfe9425f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822

JAMA Oncology

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2022, July 28). Daily insulin dose, cancer risk among patients with type 1 diabetes. Brightsurf News. https://www.brightsurf.com/news/LRD2R5M8/daily-insulin-dose-cancer-risk-among-patients-with-type-1-diabetes.html
MLA:
"Daily insulin dose, cancer risk among patients with type 1 diabetes." Brightsurf News, Jul. 28 2022, https://www.brightsurf.com/news/LRD2R5M8/daily-insulin-dose-cancer-risk-among-patients-with-type-1-diabetes.html.